Skip to content

Low-Dose Ketamine Infusion During Burn Wound Care

A Randomized, Placebo-Controlled, Double-Blind Evaluation of Low-Dose Ketamine Infusion During Burn Wound Care Procedures to Improve Pain Intensity and Reduce Opioid Consumption

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06506565
Acronym
IMPROVE
Enrollment
140
Registered
2024-07-17
Start date
2024-07-08
Completion date
2025-12-31
Last updated
2024-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn, Dissociation, Opioid, Pain

Keywords

ketamine, burn, opioid, analgesia

Brief summary

The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.

Interventions

DRUGKetamine

Infusion during wound care

DRUG0.9% NaCl

Infusion during wound care

Sponsors

University of Tennessee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

All team members and patients are blinded to study treatment, except pharmacy staff.

Intervention model description

Patients will be randomly enrolled by blocks according to age, burn size, and opioid use history. Study treatment will occur for up to 7 days. Assignment will be to placebo or ketamine and all participants and staff will be blinded, except pharmacy. Each patient will receive standard of care fentanyl and midazolam during wound care regardless of study assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to burn service with thermal injury

Exclusion criteria

* unable/unwilling to consent within 72 hours * unable to report NRS * known contraindication to ketamine * \< than 18 years of age * pregnant * incarcerated * TBSA over 50 %

Design outcomes

Primary

MeasureTime frameDescription
Analgesiaup to 7 days from enrollmentNumeric Pain Rating Scale (0 - 10, with 0 being absence of pain and 10 being the worst pain imaginable)

Countries

United States

Contacts

Primary ContactDavid M Hill, Pharm.D.
dhill19@uthsc.edu1-901-545-7100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026